Adeno-associated viruses (AAVs) have emerged as a prominent family of vectors for gene
delivery, providing therapeutic options to diseases once deemed incurable. At the same …

Recombinant adeno‐associated virus (rAAV) has emerged as an attractive gene delivery
vector platform to treat both rare and pervasive diseases. With more and more rAAV‐based …

The field of gene therapy has witnessed significant advancements in the utilization of Adeno-
associated virus (AAV) owing to its inherent biological advantages. Targeted AAV vectors …

Recombinant adeno‐associated viral vectors (rAAVs) have become an industry‐standard
technology in the field of gene therapy, but there are still challenges to be addressed in their …

Due to the success of adeno associated viruses (AAVs) in treating single-gene diseases,
improved manufacturing technology is now needed to meet their demand. The largest …

The aggregation of adeno-associated viral (AAV) capsids in an aqueous environment was
investigated via coarse-grained molecular dynamics (CG-MD) simulations. The primary …

While adeno-associated virus is a leading vector for gene therapy, significant gaps remain in
understanding AAV degradation and stability. In this work, we study the degradation of an …

The field of recombinant adeno-associated virus (rAAV) gene therapy has attracted
increasing attention over decades. Within the ongoing challenges of rAAV manufacturing …

Adeno-associated viruses (AAV) are becoming increasingly popular as a powerful tool for
gene delivery therapy applications. Although processes to produce AAV are established …

Adeno-associated viruses (AAVs) have emerged as a promising gene delivery vehicle for
the treatment of diseases. As AAVs are a complex therapeutic modality, new analytical …